Latest Breaking News On - China pharmaceutical university - Page 1 : comparemela.com

Olives Are Good At Reducing Fatty Liver | Brunei's No.1 News Website

ASCT2 inhibitors show utility in resistant NSCLC models

Alanine-serine-cysteine transporter 2 (ASCT2) is a glutamine (Gln) transporter that is required for cell proliferation and is overexpressed in tumors such as non-small-cell lung cancer (NSCLC). Researchers from China Pharmaceutical University have reported on the discovery and preclinical characterization of a novel series of ASCT2 inhibitors that led to the identification two lead compounds.

Opthea Strengthens Team with Key Clinical and Regulatory Hires

How does chronic stress harm the gut? New clues emerge

A bacterium in the intestines of stressed mice interferes with cells that protect against pathogens. A bacterium in the intestines of stressed mice interferes with cells that protect against pathogens.

Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA

NANJING, China, Jan. 4, 2024 /PRNewswire/ On December 28, 2023, Jiangsu Vcare PharmaTech Co., Ltd. (Jiangsu Vcare) successfully submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Vicagrel capsule, which is indicated to treat a range of thrombotic cardiovascular and cerebrovascular diseases, including acute coronary syndrome, ischaemic stroke, and peripheral arterial disease..